Sanofi announced today the immediate adoption of influenza strains selected by the US Food and Drug Administration (FDA) to advance the manufacturing and delivery of its vaccine ...

The Food and Drug Administration has issued recommendations for the composition of influenza shots for the upcoming ...

Cornell researchers have developed a stable, multi-target vaccine offering long-lasting protection against COVID-19 and influenza, with promising results in mice. Cornell University researchers have ...

A dividend from immunisation is a future free from the diseases that rob communities of health and well-being, a future free ...

At the end of the 2023-24 flu season, 9.2 million fewer doses were ... in seasons when the vaccine's effectiveness is low, it ...

Flu-related fatalities nearly double compared to previous year, with 20 adults and 2 children among the victims.

The “swine flu” virus was distinct enough from ... do not trigger a strong immune response, unless the dose of vaccine used is very high, or an adjuvant — a compound that amplifies the ...

In February 2025, flu rates ... when the vaccine’s effectiveness is low, it is likely to offer better protection compared with remaining unvaccinated. Handwashing and disinfecting high-traffic ...

But drugmakers can’t actually start making the doses until the FDA selects the strains. Shots are usually available by the end of July or early August, said Litjen Tan, co-chair of the flu shot ...

(JTA) — Israel has begun inviting immunocompromised adults to receive a third dose of the COVID-19 vaccine, as case rates in the country have risen again due to the spread of the Delta variant.